Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: results from a phase III trial.
Read MoreADT and the risk of cardiovascular disease and mortality – – A moving target
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association.
Read MoreDid your doctor mention to you the pros and cons of an orchiectomy?
Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.
Read MoreCan lifestyle changes improve markers of metabolic and cardiovascular health in men on ADT?
Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer.
Read MoreFor men with high-risk prostate cancer, is there benefit in taking ADT for at least one year after radiation therapy?
Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.
Read MoreAnd yet another paper on the psychological impact of ADT
Analysis of Brain Functions in Men with Prostate Cancer under Androgen Deprivation Therapy: A One-Year Longitudinal Study.
Read MoreHow effective is Lupron in suppressing testosterone?
Effectiveness and Distribution of Testosterone Levels within First Year of Androgen Deprivation Therapy in a Real-World Setting: Results from the Non-Interventional German Cohort LEAN Study.
Read MoreFor men on ADT, do the benefits of statins go beyond cholesterol control?
The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy.
Read MoreIs there any benefit to starting ADT before a radical prostatectomy?
Do androgen-directed therapies improve outcomes in prostate cancer patients undergoing radical prostatectomy? A systematic review and meta-analysis.
Read MoreOnce Again, Research Suggests ADT Increases the Risk of Dementia and Alzheimer Disease
The Risk of New Onset Dementia and/or Alzheimer Disease among Patients with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.
Read More